nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—SRC—periosteum—periodontitis	0.0331	0.0907	CbGeAlD
Ponatinib—Imatinib—NTRK1—periodontitis	0.0172	1	CrCbGaD
Ponatinib—FGFR4—connective tissue—periodontitis	0.0152	0.0416	CbGeAlD
Ponatinib—TEK—endothelium—periodontitis	0.0137	0.0376	CbGeAlD
Ponatinib—SRC—endothelium—periodontitis	0.0122	0.0334	CbGeAlD
Ponatinib—KDR—endothelium—periodontitis	0.0112	0.0308	CbGeAlD
Ponatinib—FGFR2—mouth—periodontitis	0.0111	0.0303	CbGeAlD
Ponatinib—BCR—trigeminal ganglion—periodontitis	0.0108	0.0296	CbGeAlD
Ponatinib—LYN—connective tissue—periodontitis	0.0104	0.0285	CbGeAlD
Ponatinib—FGFR3—connective tissue—periodontitis	0.0104	0.0284	CbGeAlD
Ponatinib—BCR—parotid gland—periodontitis	0.0102	0.0279	CbGeAlD
Ponatinib—KIT—endothelium—periodontitis	0.00995	0.0273	CbGeAlD
Ponatinib—RET—neck—periodontitis	0.00995	0.0273	CbGeAlD
Ponatinib—FGFR3—epithelium—periodontitis	0.00983	0.0269	CbGeAlD
Ponatinib—FGFR1—trigeminal ganglion—periodontitis	0.0096	0.0263	CbGeAlD
Ponatinib—FGFR2—neck—periodontitis	0.00946	0.0259	CbGeAlD
Ponatinib—FLT3—connective tissue—periodontitis	0.0089	0.0244	CbGeAlD
Ponatinib—LCK—trigeminal ganglion—periodontitis	0.00859	0.0235	CbGeAlD
Ponatinib—RET—trigeminal ganglion—periodontitis	0.00859	0.0235	CbGeAlD
Ponatinib—TEK—trigeminal ganglion—periodontitis	0.00783	0.0214	CbGeAlD
Ponatinib—KIT—mouth—periodontitis	0.00768	0.021	CbGeAlD
Ponatinib—KDR—neck—periodontitis	0.00741	0.0203	CbGeAlD
Ponatinib—RET—connective tissue—periodontitis	0.00713	0.0195	CbGeAlD
Ponatinib—FGFR2—connective tissue—periodontitis	0.00678	0.0186	CbGeAlD
Ponatinib—RET—epithelium—periodontitis	0.00677	0.0186	CbGeAlD
Ponatinib—KIT—neck—periodontitis	0.00657	0.018	CbGeAlD
Ponatinib—TEK—connective tissue—periodontitis	0.0065	0.0178	CbGeAlD
Ponatinib—FGFR2—epithelium—periodontitis	0.00643	0.0176	CbGeAlD
Ponatinib—KDR—trigeminal ganglion—periodontitis	0.0064	0.0175	CbGeAlD
Ponatinib—TEK—epithelium—periodontitis	0.00617	0.0169	CbGeAlD
Ponatinib—KDR—parotid gland—periodontitis	0.00603	0.0165	CbGeAlD
Ponatinib—PDGFRA—connective tissue—periodontitis	0.00589	0.0161	CbGeAlD
Ponatinib—SRC—connective tissue—periodontitis	0.00577	0.0158	CbGeAlD
Ponatinib—KIT—trigeminal ganglion—periodontitis	0.00567	0.0155	CbGeAlD
Ponatinib—SRC—epithelium—periodontitis	0.00548	0.015	CbGeAlD
Ponatinib—KIT—parotid gland—periodontitis	0.00535	0.0147	CbGeAlD
Ponatinib—KDR—connective tissue—periodontitis	0.00531	0.0145	CbGeAlD
Ponatinib—KDR—epithelium—periodontitis	0.00504	0.0138	CbGeAlD
Ponatinib—ABL1—trigeminal ganglion—periodontitis	0.00494	0.0135	CbGeAlD
Ponatinib—KIT—connective tissue—periodontitis	0.00471	0.0129	CbGeAlD
Ponatinib—ABL1—parotid gland—periodontitis	0.00466	0.0128	CbGeAlD
Ponatinib—KIT—epithelium—periodontitis	0.00447	0.0122	CbGeAlD
Ponatinib—ABL1—connective tissue—periodontitis	0.0041	0.0112	CbGeAlD
Ponatinib—ABCG2—trigeminal ganglion—periodontitis	0.00311	0.00853	CbGeAlD
Ponatinib—ABCG2—parotid gland—periodontitis	0.00294	0.00804	CbGeAlD
Ponatinib—ABCB1—trigeminal ganglion—periodontitis	0.00153	0.0042	CbGeAlD
Ponatinib—ABCB1—epithelium—periodontitis	0.00121	0.00331	CbGeAlD
Ponatinib—CYP3A5—Metabolism—ACP5—periodontitis	8.31e-05	0.000134	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—MMP9—periodontitis	8.3e-05	0.000134	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CXCR2—periodontitis	8.29e-05	0.000134	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CRP—periodontitis	8.29e-05	0.000134	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CRP—periodontitis	8.27e-05	0.000134	CbGpPWpGaD
Ponatinib—FGFR1—Axon guidance—IL6—periodontitis	8.25e-05	0.000133	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—VIP—periodontitis	8.24e-05	0.000133	CbGpPWpGaD
Ponatinib—SRC—Immune System—TLR2—periodontitis	8.21e-05	0.000133	CbGpPWpGaD
Ponatinib—LYN—Cytokine Signaling in Immune system—IL6—periodontitis	8.15e-05	0.000132	CbGpPWpGaD
Ponatinib—FGFR3—Innate Immune System—IL6—periodontitis	8.11e-05	0.000131	CbGpPWpGaD
Ponatinib—LCK—Immune System—VCAM1—periodontitis	8.07e-05	0.000131	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—IL1B—periodontitis	8.06e-05	0.000131	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—MMP2—periodontitis	8.05e-05	0.00013	CbGpPWpGaD
Ponatinib—FGFR3—Disease—PTGS2—periodontitis	8e-05	0.00013	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—IL6—periodontitis	8e-05	0.000129	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—TLR4—periodontitis	7.94e-05	0.000129	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—TLR4—periodontitis	7.92e-05	0.000128	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CCR2—periodontitis	7.87e-05	0.000127	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—ADRB1—periodontitis	7.83e-05	0.000127	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—NTRK1—periodontitis	7.82e-05	0.000127	CbGpPWpGaD
Ponatinib—FGFR4—Disease—TGFB1—periodontitis	7.82e-05	0.000127	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—TGFB1—periodontitis	7.81e-05	0.000126	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—TGFB1—periodontitis	7.77e-05	0.000126	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD79A—periodontitis	7.72e-05	0.000125	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—NTRK1—periodontitis	7.68e-05	0.000124	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—FGF2—periodontitis	7.65e-05	0.000124	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—FGF2—periodontitis	7.63e-05	0.000123	CbGpPWpGaD
Ponatinib—SRC—NGF signalling via TRKA from the plasma membrane—IL6—periodontitis	7.56e-05	0.000122	CbGpPWpGaD
Ponatinib—FGFR2—Disease—NOS2—periodontitis	7.49e-05	0.000121	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD14—periodontitis	7.4e-05	0.00012	CbGpPWpGaD
Ponatinib—KIT—Disease—NOS2—periodontitis	7.35e-05	0.000119	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—CXCL8—periodontitis	7.35e-05	0.000119	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CXCR2—periodontitis	7.34e-05	0.000119	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—FGF2—periodontitis	7.32e-05	0.000119	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—TNF—periodontitis	7.29e-05	0.000118	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—NTRK1—periodontitis	7.29e-05	0.000118	CbGpPWpGaD
Ponatinib—LYN—Immune System—CRP—periodontitis	7.29e-05	0.000118	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—MMP3—periodontitis	7.27e-05	0.000118	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—NTRK1—periodontitis	7.27e-05	0.000118	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CRP—periodontitis	7.26e-05	0.000117	CbGpPWpGaD
Ponatinib—LYN—Axon guidance—IL6—periodontitis	7.26e-05	0.000117	CbGpPWpGaD
Ponatinib—ABL1—Axon guidance—IL6—periodontitis	7.22e-05	0.000117	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ACP5—periodontitis	7.2e-05	0.000116	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL1A—periodontitis	7.15e-05	0.000116	CbGpPWpGaD
Ponatinib—SRC—Immune System—VCAM1—periodontitis	7.14e-05	0.000116	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—MMP3—periodontitis	7.14e-05	0.000116	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL18—periodontitis	7.13e-05	0.000115	CbGpPWpGaD
Ponatinib—LYN—Immune System—TLR4—periodontitis	6.99e-05	0.000113	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—PPARA—periodontitis	6.98e-05	0.000113	CbGpPWpGaD
Ponatinib—FGFR1—Disease—NOS2—periodontitis	6.98e-05	0.000113	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—NOS2—periodontitis	6.96e-05	0.000113	CbGpPWpGaD
Ponatinib—ABL1—Immune System—TLR4—periodontitis	6.96e-05	0.000113	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—CCL2—periodontitis	6.87e-05	0.000111	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—TGFB1—periodontitis	6.87e-05	0.000111	CbGpPWpGaD
Ponatinib—LCK—Immune System—AGER—periodontitis	6.85e-05	0.000111	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—TGFB1—periodontitis	6.84e-05	0.000111	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—MMP3—periodontitis	6.78e-05	0.00011	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—MMP3—periodontitis	6.76e-05	0.000109	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—FGF2—periodontitis	6.75e-05	0.000109	CbGpPWpGaD
Ponatinib—LYN—Hemostasis—TGFB1—periodontitis	6.74e-05	0.000109	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—TGFB1—periodontitis	6.71e-05	0.000109	CbGpPWpGaD
Ponatinib—LCK—Cytokine Signaling in Immune system—IL6—periodontitis	6.68e-05	0.000108	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—MMP9—periodontitis	6.65e-05	0.000108	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—FGF2—periodontitis	6.61e-05	0.000107	CbGpPWpGaD
Ponatinib—LCK—Signaling by NGF—IL6—periodontitis	6.57e-05	0.000106	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—SLC52A3—periodontitis	6.55e-05	0.000106	CbGpPWpGaD
Ponatinib—KIT—Immune System—FGF2—periodontitis	6.49e-05	0.000105	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—FGF2—periodontitis	6.48e-05	0.000105	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—GGT1—periodontitis	6.45e-05	0.000104	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CCR2—periodontitis	6.45e-05	0.000104	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—periodontitis	6.43e-05	0.000104	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—ADRB1—periodontitis	6.42e-05	0.000104	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—TNF—periodontitis	6.42e-05	0.000104	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—NTRK1—periodontitis	6.41e-05	0.000104	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—TNF—periodontitis	6.39e-05	0.000103	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—IL6—periodontitis	6.38e-05	0.000103	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL1A—periodontitis	6.33e-05	0.000102	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL18—periodontitis	6.32e-05	0.000102	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	6.31e-05	0.000102	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ACP5—periodontitis	6.27e-05	0.000101	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—IFNG—periodontitis	6.22e-05	0.000101	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—FGF2—periodontitis	6.21e-05	0.000101	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—FGF2—periodontitis	6.16e-05	9.97e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—FGF2—periodontitis	6.14e-05	9.95e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—IFNG—periodontitis	6.11e-05	9.89e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—FGF2—periodontitis	6.1e-05	9.88e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—AGER—periodontitis	6.07e-05	9.82e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—MMP9—periodontitis	6.05e-05	9.79e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—FGF2—periodontitis	5.99e-05	9.7e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—CCL2—periodontitis	5.99e-05	9.69e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—CRP—periodontitis	5.98e-05	9.67e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MMP3—periodontitis	5.96e-05	9.65e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ACP5—periodontitis	5.91e-05	9.56e-05	CbGpPWpGaD
Ponatinib—FGFR4—Disease—IL6—periodontitis	5.89e-05	9.54e-05	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	5.89e-05	9.54e-05	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—IL6—periodontitis	5.89e-05	9.53e-05	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—IL6—periodontitis	5.86e-05	9.48e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling by NGF—IL6—periodontitis	5.82e-05	9.42e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IFNG—periodontitis	5.8e-05	9.38e-05	CbGpPWpGaD
Ponatinib—FGFR3—Disease—TGFB1—periodontitis	5.79e-05	9.37e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IFNG—periodontitis	5.78e-05	9.36e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—TLR4—periodontitis	5.73e-05	9.27e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CCR2—periodontitis	5.71e-05	9.24e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—FGF2—periodontitis	5.69e-05	9.21e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—ADRB1—periodontitis	5.68e-05	9.2e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—FGF2—periodontitis	5.67e-05	9.18e-05	CbGpPWpGaD
Ponatinib—FGFR2—Innate Immune System—IL6—periodontitis	5.58e-05	9.03e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—IL1B—periodontitis	5.55e-05	8.98e-05	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—TGFB1—periodontitis	5.52e-05	8.94e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—PTGS2—periodontitis	5.5e-05	8.91e-05	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—TGFB1—periodontitis	5.48e-05	8.87e-05	CbGpPWpGaD
Ponatinib—KIT—Innate Immune System—IL6—periodontitis	5.48e-05	8.86e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—IL1B—periodontitis	5.45e-05	8.82e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—CXCL8—periodontitis	5.44e-05	8.8e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—FGF2—periodontitis	5.42e-05	8.77e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—FGF2—periodontitis	5.41e-05	8.76e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—PTGS2—periodontitis	5.41e-05	8.75e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—FGF2—periodontitis	5.39e-05	8.73e-05	CbGpPWpGaD
Ponatinib—ABCB1—Transmembrane transport of small molecules—PPARA—periodontitis	5.33e-05	8.62e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—CRP—periodontitis	5.29e-05	8.56e-05	CbGpPWpGaD
Ponatinib—SRC—Axon guidance—IL6—periodontitis	5.26e-05	8.52e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—NTRK1—periodontitis	5.26e-05	8.51e-05	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—IL6—periodontitis	5.2e-05	8.41e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—IL6—periodontitis	5.18e-05	8.39e-05	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—IL6—periodontitis	5.18e-05	8.38e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IL1B—periodontitis	5.17e-05	8.37e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IL1B—periodontitis	5.16e-05	8.35e-05	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—IL6—periodontitis	5.15e-05	8.34e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—PTGS2—periodontitis	5.13e-05	8.3e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—PTGS2—periodontitis	5.12e-05	8.28e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—IFNG—periodontitis	5.1e-05	8.25e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IFNG—periodontitis	5.08e-05	8.22e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—TLR4—periodontitis	5.07e-05	8.21e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—NOS2—periodontitis	5.03e-05	8.14e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—TGFB1—periodontitis	4.99e-05	8.07e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—MMP9—periodontitis	4.92e-05	7.96e-05	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—TGFB1—periodontitis	4.89e-05	7.92e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MMP3—periodontitis	4.89e-05	7.91e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—CXCL8—periodontitis	4.73e-05	7.66e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CCL2—periodontitis	4.73e-05	7.65e-05	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—IL6—periodontitis	4.72e-05	7.64e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—TNF—periodontitis	4.66e-05	7.54e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—NTRK1—periodontitis	4.65e-05	7.53e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CCL2—periodontitis	4.64e-05	7.52e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—GGT1—periodontitis	4.62e-05	7.48e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PPARA—periodontitis	4.62e-05	7.47e-05	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—IL6—periodontitis	4.57e-05	7.4e-05	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—IL6—periodontitis	4.55e-05	7.37e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL1B—periodontitis	4.55e-05	7.36e-05	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—PTGS2—periodontitis	4.54e-05	7.35e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL1B—periodontitis	4.53e-05	7.33e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—NOS2—periodontitis	4.45e-05	7.21e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—FGF2—periodontitis	4.44e-05	7.19e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CCL2—periodontitis	4.41e-05	7.13e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CCL2—periodontitis	4.4e-05	7.12e-05	CbGpPWpGaD
Ponatinib—FGFR3—Disease—IL6—periodontitis	4.36e-05	7.06e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MMP3—periodontitis	4.33e-05	7e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—MMP9—periodontitis	4.28e-05	6.93e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—FGF2—periodontitis	4.27e-05	6.92e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—FGF2—periodontitis	4.2e-05	6.79e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	4.18e-05	6.77e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IFNG—periodontitis	4.18e-05	6.77e-05	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—IL6—periodontitis	4.13e-05	6.68e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—FGF2—periodontitis	4.1e-05	6.64e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TGFB1—periodontitis	4.05e-05	6.56e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—GGT1—periodontitis	4e-05	6.48e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—FGF2—periodontitis	3.98e-05	6.45e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—TGFB1—periodontitis	3.98e-05	6.44e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—FGF2—periodontitis	3.97e-05	6.43e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—FGF2—periodontitis	3.93e-05	6.37e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—TGFB1—periodontitis	3.91e-05	6.33e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CCL2—periodontitis	3.88e-05	6.28e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ACP5—periodontitis	3.86e-05	6.25e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—IL6—periodontitis	3.76e-05	6.08e-05	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—IL6—periodontitis	3.75e-05	6.07e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CXCL8—periodontitis	3.74e-05	6.05e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL1B—periodontitis	3.73e-05	6.03e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—TGFB1—periodontitis	3.71e-05	6e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IFNG—periodontitis	3.7e-05	5.99e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—PTGS2—periodontitis	3.7e-05	5.99e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—TGFB1—periodontitis	3.7e-05	5.99e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CXCL8—periodontitis	3.67e-05	5.94e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—FGF2—periodontitis	3.63e-05	5.88e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TGFB1—periodontitis	3.53e-05	5.71e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—FGF2—periodontitis	3.5e-05	5.67e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GGT1—periodontitis	3.49e-05	5.64e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CXCL8—periodontitis	3.48e-05	5.64e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CXCL8—periodontitis	3.48e-05	5.63e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—MMP9—periodontitis	3.38e-05	5.47e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—MMP9—periodontitis	3.32e-05	5.38e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—IL6—periodontitis	3.32e-05	5.37e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PPARA—periodontitis	3.31e-05	5.35e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL1B—periodontitis	3.3e-05	5.34e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GGT1—periodontitis	3.29e-05	5.32e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—PTGS2—periodontitis	3.28e-05	5.3e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—IL6—periodontitis	3.25e-05	5.26e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—IL6—periodontitis	3.19e-05	5.16e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CCL2—periodontitis	3.18e-05	5.14e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—MMP9—periodontitis	3.15e-05	5.1e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—MMP9—periodontitis	3.14e-05	5.09e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CXCL8—periodontitis	3.07e-05	4.96e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—IL6—periodontitis	3.05e-05	4.94e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IL6—periodontitis	3.03e-05	4.9e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IL6—periodontitis	3.02e-05	4.89e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PTGS2—periodontitis	3e-05	4.86e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—IL6—periodontitis	3e-05	4.85e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—IL6—periodontitis	2.95e-05	4.77e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—FGF2—periodontitis	2.87e-05	4.65e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PPARA—periodontitis	2.86e-05	4.64e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CCL2—periodontitis	2.81e-05	4.55e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—IL6—periodontitis	2.79e-05	4.52e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—IL6—periodontitis	2.79e-05	4.51e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TGFB1—periodontitis	2.79e-05	4.51e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MMP9—periodontitis	2.77e-05	4.49e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TGFB1—periodontitis	2.74e-05	4.43e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—TGFB1—periodontitis	2.67e-05	4.33e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL6—periodontitis	2.66e-05	4.31e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—IL6—periodontitis	2.66e-05	4.31e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL6—periodontitis	2.65e-05	4.29e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TGFB1—periodontitis	2.6e-05	4.2e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TGFB1—periodontitis	2.59e-05	4.19e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—FGF2—periodontitis	2.54e-05	4.12e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CXCL8—periodontitis	2.51e-05	4.07e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PPARA—periodontitis	2.5e-05	4.04e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—TGFB1—periodontitis	2.37e-05	3.83e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PPARA—periodontitis	2.35e-05	3.81e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TGFB1—periodontitis	2.29e-05	3.7e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MMP9—periodontitis	2.27e-05	3.68e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CXCL8—periodontitis	2.22e-05	3.6e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL6—periodontitis	2.18e-05	3.53e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PTGS2—periodontitis	2.15e-05	3.48e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GGT1—periodontitis	2.15e-05	3.48e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—IL6—periodontitis	2.1e-05	3.4e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—IL6—periodontitis	2.06e-05	3.34e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—IL6—periodontitis	2.02e-05	3.26e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MMP9—periodontitis	2.01e-05	3.26e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IL6—periodontitis	1.96e-05	3.17e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IL6—periodontitis	1.95e-05	3.16e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL6—periodontitis	1.93e-05	3.13e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TGFB1—periodontitis	1.87e-05	3.03e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PTGS2—periodontitis	1.86e-05	3.01e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—IL6—periodontitis	1.78e-05	2.89e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL6—periodontitis	1.72e-05	2.79e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TGFB1—periodontitis	1.66e-05	2.68e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PTGS2—periodontitis	1.62e-05	2.63e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PPARA—periodontitis	1.54e-05	2.49e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PTGS2—periodontitis	1.53e-05	2.48e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL6—periodontitis	1.41e-05	2.28e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL6—periodontitis	1.25e-05	2.02e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTGS2—periodontitis	1e-05	1.62e-05	CbGpPWpGaD
